REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
The critical features of ferroptosis have been observed in the models of AD, epilepsy, stroke, and Parkinsons disease (PD), including loss of glutathione, increased ROS, decreased GPX4, and lipid peroxidation
Their potential lies in their ability to support the skin's natural renewal processes
The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
The most widely used anti-angiogenic agents include monoclonal antibodies and tyrosine kinase inhibitors (TKIs) targeting vascular endothelial growth factor (VEGF) pathway
